急诊科完整一小时脓毒症集束化治疗的28天死亡率结局
该前瞻性队列研究纳入2019年3月至7月一家三级医院急诊科收治的593例成人脓毒症患者,按急诊脓毒症方案管理,55.9%完成完整一小时脓毒症集束化治疗。总体28天死亡率为3.9%,完整组与不完整组分别为3.6%与4.2%,差异无统计学意义(P=0.707)。完整集束化治疗与28天死亡率(调整OR=2.04,95%CI 0.72-5.74,P=0.176)及延迟性脓毒性休克(调整OR=0.74,95%CI 0.30-1.78,P=0.499)均无显著关联,完成各单项集束措施亦未影响上述结局。作者结论认为急诊完整一小时集束化治疗与28天死亡率和延迟性脓毒性休克无显著关联。
要点
- 593例急诊成人脓毒症中55.9%完成完整一小时集束化治疗,总体28天死亡率3.9%。
- 完整组与不完整组28天死亡率分别为3.6%与4.2%,差异无统计学意义(P=0.707)。
- 完整集束化治疗与28天死亡率无显著关联(调整OR=2.04,95%CI 0.72-5.74,P=0.176)。
- 完整集束化治疗与延迟性脓毒性休克无显著关联(调整OR=0.74,95%CI 0.30-1.78,P=0.499)。
- 完成各单项集束措施均未影响28天死亡率与延迟性脓毒性休克结局。
适用人群与场景
- 2019年3月至7月一家三级医院急诊科收治的成人脓毒症患者,共593例。
处置流程与药物剂量
- 按该三级医院急诊科使用的脓毒症方案管理,采用完整或不完整的一小时脓毒症集束化治疗。
研究设计与关键结果
- 前瞻性队列研究,纳入593例急诊成人脓毒症患者,55.9%在完整一小时脓毒症集束化治疗组。
- 总体28天死亡率为3.9%,完整组与不完整组分别为3.6%与4.2%,差异无统计学意义(P=0.707)。
- 完整一小时集束化治疗与28天死亡率无显著关联(调整OR=2.04,95%CI 0.72-5.74,P=0.176)。
- 完整一小时集束化治疗与延迟性脓毒性休克无显著关联(调整OR=0.74,95%CI 0.30-1.78,P=0.499)。
- 完成各单项集束措施均未影响28天死亡率与延迟性脓毒性休克结局。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为急诊完整一小时脓毒症集束化治疗与28天死亡率及延迟性脓毒性休克无显著关联。
指南或共识出处
- Surviving Sepsis Campaign于2018年发布的一小时脓毒症集束化治疗(Hour-1 Sepsis Bundle)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The Surviving Sepsis Campaign published the Hour-1 Sepsis Bundle in 2018. The first-hour management of patients with sepsis in the emergency department (ED) is important, as suggested in the Hour-1 Sepsis Bundle. The objectives of the present study were to evaluate 28-day mortality and delayed septic shock with use of a complete and incomplete Hour-1 Sepsis Bundle in the ED.
METHODS: This prospective cohort study included adult patients with sepsis from March to July 2019. We followed the sepsis protocol used in the ED of a tertiary care hospital.
RESULTS: We enrolled 593 patients, with 55.9% in the complete Hour-1 Sepsis Bundle group. The 28-day mortality was 3.9% overall and no significant difference between the complete and incomplete Hour-1 Sepsis Bundle groups (3.6% vs. 4.2%, P = 0.707). Complete Hour-1 Sepsis Bundle treatment was not associated with 28-day mortality (adjusted OR = 2.04, 95% confidence interval [CI] = 0.72-5.74, P = 0.176) or delayed septic shock (adjusted OR = 0.74, 95% CI = 0.30-1.78, P = 0.499). Completion of each bundle did not affect outcomes of 28-day mortality and delayed septic shock.
CONCLUSIONS: The complete Hour-1 Sepsis Bundle treatment in the ED was not significantly associated with 28-day mortality and delayed septic shock.
TRIAL REGISTRATION: The trial was registered in the Thai Clinical Trial Registry, TCTR 20200526013.
参考来源
- Prachanukool T, Sanguanwit P, Thodamrong F, et al. The 28-Day Mortality Outcome of the Complete Hour-1 Sepsis Bundle in the Emergency Department. Shock. 2021. PMID: 34779799. doi:10.1097/SHK.0000000000001815
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。